Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Team Novo Nordisk sign Polish Track Star and Olympic Hopeful Mateusz Rudyk

Team Novo Nordisk is proud to announce the signing of the Polish track sprinter Mateusz Rudyk for the 2021 season.


News provided by

Team Novo Nordisk

Feb 09, 2021, 11:00 ET

Share this article

Share toX

Share this article

Share toX

©Szymon Gruchalski
©Szymon Gruchalski

ATLANTA, Feb. 9, 2021 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all diabetes professional cycling team, today announced the signing of 2016 UEC European team sprint gold medalist Mateusz Rudyk.

Rudyk will continue to race and compete on the track as he prepares for the upcoming Tokyo Olympics. Diagnosed with type 1 diabetes at age 12, Rudyk joins 18-time US National Champion Mandy Marquardt as Team Novo Nordisk's second fully supported professional track athlete.

''Mateusz is a really good young man, goal orientated, and has a big dream for Tokyo. The fact that one of the world’s top track sprinters is joining Team Novo Nordisk is a big boost to all of us,” said Team Novo Nordisk CEO and Co-Founder Phil Southerland.

Post this

"Joining Team Novo Nordisk is an important stage in my career," began Rudyk. "The team consists of people with diabetes, just like me, and it shows that with diabetes you can be a professional athlete and achieve high results in sports."

"The Olympic Games are my main goal. I want to fight for a medal, and I believe in myself. My goal is to show people that with diabetes I am able to be the best in the world."

Boasting an impressive pedigree on the track, Rudyk won a bronze medal in the individual sprint at the 2019 World Championships in Pruszków and another bronze in the individual sprint at the 2019 European Championships in Apeldoorn.

With the Tokyo Olympics the big goal for 2021, Rudyk and Team Novo Nordisk will work together over the coming months to provide the best possible environment for Rudyk to train and prepare for Tokyo.

"First and foremost, Mateusz is a really good young man, goal orientated, and has a big dream for Tokyo," said Team Novo Nordisk CEO and Co-Founder Phil Southerland. "The fact that one of the world's top track sprinters is joining Team Novo Nordisk is a big boost to all of us. He and Mandy have developed a friendship, and to think we have the chance at both male and female Olympians from Team Novo Nordisk is truly a dream come true."

"Mateusz doesn't just want a medal at the Olympics, but he wants to leverage that visibility as a means to educate, empower, and inspire the diabetes community. I really look forward to working with him, helping him not only in his sporting goals, but to see his role as a hero for all of us with diabetes come to fruition. Together, we will be stronger. Together our message will go farther. And together we will be changing diabetes for the world, one person at a time."

2021 is a major milestone and anniversary for all of the people living with diabetes around the world as it marks the 100th year anniversary of the discovery of insulin.

Keenly aware of the significance of 2021 for the diabetes community and particularly for Team Novo Nordisk, Rudyk is thankful for the opportunity joining the team presents.

"This is an important year for everyone with diabetes," continued Rudyk. "If not for the discovery of insulin, life with this disease would have been completely different. I cannot imagine my life without insulin, it accompanies me all the time and it is one of the most important elements of living with diabetes."

Rudyk's first contact with Team Novo Nordisk came years earlier as a visitor to the team bus at his home Tour in Poland and after the first wheels were set in motion, the team finally had their man.

"We met Mateusz a few years ago at the Tour du Pologne and we have been developing a relationship since then" said General Manager Vassili Davidenko. "He is one of the world's top track sprinters and a great example for everyone to see what is possible with diabetes. 2021 is an Olympic year and also 100 years since the discovery of insulin. What better way to showcase the importance of this than with Team Novo Nordisk athletes doing well at the Olympics."

"With our structure and support within the team we want to provide Mateusz with all the help necessary to help him achieve his goals and show the world that diabetes isn't a barrier to achieving Olympic success."

Team Novo Nordisk is set to begin the 2021 season at the Trofeo Laigueglia in Italy on March 3rd.

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

Media Contacts:
Tim Lindley for Team Novo Nordisk
[email protected]
+1-803-762-4713 (U.S.)
+39 3911106499 (Italy)

Media Contact

Tim Lindley, Team Novo Nordisk, 803-762-4713, [email protected]

Twitter, LinkedIn, Facebook

SOURCE Team Novo Nordisk

Related Links

http://www.teamnovonordisk.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.